https://z-ietd-fmk.com/index.p....hp/epigenetics-as-we
Conclusion FME utilizing EMI-137 appeared to be safe and possible within a one-to-three time dose-to-imaging period. No clinically considerable variations were observed between the cohorts, although a one-hour dose-to-imaging period ended up being preferred from a clinical viewpoint. Future researches will research EMI-137 for improved colorectal polyp recognition during testing colonoscopies. Copyright © 2020 by the Society of Nuclear Medicine and Molecular Imaging, Inc.Purpose to look fo
Like
Comment
Share
